Inhibition of proliferation and migration of melanoma cells by ketoconazole and

Ganoderma microsporum adenosine monophosphate-activated protein kinase ketoconazole melanoma monocyte chemoattractant protein-1

Journal

Oncology letters
ISSN: 1792-1074
Titre abrégé: Oncol Lett
Pays: Greece
ID NLM: 101531236

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 08 02 2018
accepted: 07 03 2019
entrez: 11 7 2019
pubmed: 11 7 2019
medline: 11 7 2019
Statut: ppublish

Résumé

Ketoconazole, an antifungal agent, has been used to inhibit hormone synthesis in types of prostate and breast cancer. Immunomodulatory proteins of

Identifiants

pubmed: 31289567
doi: 10.3892/ol.2019.10355
pii: OL-0-0-10355
pmc: PMC6539804
doi:

Types de publication

Journal Article

Langues

eng

Pagination

891-897

Références

J Lipid Res. 2006 Feb;47(2):412-20
pubmed: 16304351
Cancer. 2006 Jun 1;106(11):2459-65
pubmed: 16615097
J Invest Dermatol. 2007 Aug;127(8):2031-41
pubmed: 17460736
Clin Ther. 2009;31 Pt 2:2444-58
pubmed: 20110052
J Urol. 2010 Jun;183(6):2219-26
pubmed: 20399458
J Agric Food Chem. 2010 Nov 24;58(22):12014-21
pubmed: 21028821
Proc Natl Acad Sci U S A. 2011 Apr 19;108(16):6597-602
pubmed: 21460252
Autophagy. 2011 Aug;7(8):873-82
pubmed: 21490426
Biochem Pharmacol. 2012 Feb 1;83(3):385-94
pubmed: 22120676
J Clin Invest. 2013 Mar;123(3):1371-81
pubmed: 23454771
Mol Cancer Ther. 2013 Aug;12(8):1605-15
pubmed: 23741061
Anticancer Res. 2013 Jun;33(6):2499-508
pubmed: 23749901
Int J Pharm. 2014 Sep 10;472(1-2):214-23
pubmed: 24954663
Curr Opin Cell Biol. 2015 Apr;33:1-7
pubmed: 25259783
Prostate. 2015 Apr 1;75(5):527-38
pubmed: 25586052
Mol Pharm. 2015 May 4;12(5):1534-43
pubmed: 25811903
PLoS One. 2015 May 06;10(5):e0125774
pubmed: 25946033
Cancer Res. 2015 Sep 1;75(17):3529-42
pubmed: 26330165
Clin Cancer Res. 2017 Jan 1;23(1):137-148
pubmed: 27354473
Cancer Res. 2016 Oct 1;76(19):5671-5682
pubmed: 27530322
Br J Clin Pharmacol. 2017 Apr;83(4):846-854
pubmed: 27859472
Int J Cancer. 2017 Jul 15;141(2):405-413
pubmed: 28340497
Oncotarget. 2017 Jul 31;8(41):70422-70430
pubmed: 29050290
Oncol Lett. 2017 Nov;14(5):5831-5838
pubmed: 29113214
J Clin Oncol. 1994 Apr;12(4):683-8
pubmed: 7512126

Auteurs

Chun-Te Lu (CT)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Division of Plastic and Reconstructive Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung 40705, Taiwan, R.O.C.

Pui-Ying Leong (PY)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Department of Rheumatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C.

Ting-Yi Hou (TY)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.

Yu-Ting Kang (YT)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.

Yan-Cheng Chiang (YC)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Department of Dermatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C.

Chih-Ting Hsu (CT)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.

Yan-De Lin (YD)

Department of Medical Laboratory and Biotechnology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C.

Jiunn-Liang Ko (JL)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Department of Medical Oncology and Chest Medicine, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C.

Yu-Ping Hsiao (YP)

Institute of Medicine, School of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan, R.O.C.
Department of Dermatology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan, R.O.C.

Classifications MeSH